Related Experiment Video
Updated: Apr 24, 2026
07:49
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
3.0K
Mitochondrial substrates in cancer: drivers or passengers?
Björn Kruspig1, Boris Zhivotovsky2, Vladimir Gogvadze2
1Division of Toxicology, Institute of Environmental Medicine Karolinska Institutet, Box 210 171 77 Stockholm, Sweden.
Mitochondrion
|September 3, 2014
Summary
Cancer cells reprogram their metabolism, often relying on glycolysis over mitochondrial function. Alterations in mitochondrial substrates drive this metabolic switch, highlighting mitochondria as potential anti-cancer therapy targets.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Most cancers exhibit unique metabolic changes, including elevated glycolysis (Warburg effect) even with oxygen present.
- Mitochondrial metabolic activity is often reduced in cancer cells, impacting cellular energy production.
- Dysregulation of mitochondrial substrate metabolism is a key mechanism behind cancer's metabolic reprogramming.
Purpose of the Study:
- To investigate the role of mitochondrial metabolic aberrations in cancer.
- To explore the connection between altered mitochondrial substrates and tumorigenesis.
- To provide a rationale for targeting mitochondria in anti-cancer strategies.
Main Methods:
- Analysis of metabolic pathways in cancer cells.
- Examination of mitochondrial substrate utilization and localization.
- Review of existing evidence linking mitochondrial dysfunction to cancer.
Main Results:
- Confirmed significant metabolic reprogramming in the majority of cancers.
- Identified alterations in mitochondrial substrate abundance, utilization, and localization as critical.
- Established a strong link between disturbed mitochondrial metabolism and cancer development.
Conclusions:
- Mitochondrial metabolic alterations are central to cancer's metabolic phenotype.
- Targeting mitochondrial pathways presents a promising avenue for novel cancer therapies.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
11.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.8K
02:53Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
02:53Adaptive Mechanisms in Cancer Cells
3.8K
3.8K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
03:03mTOR Signaling and Cancer Progression
1.5K
1.5K
01:39Mitochondrial Precursor Proteins
2.9K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.9K